Nov 29, 2010 6:30pm EST Immunovaccine Signs Research Agreement with OncoTherapy Science to Advance Potential Cancer Vaccine
Nov 17, 2010 5:43am EST Immunovaccine Inc. Announces Phase I/II Clinical Plan for DPX-Survivac to Target Ovarian Cancer
Nov 08, 2010 3:37pm EST Immunovaccine Inc. Successfully Formulates Cel-Sci's CEL-2000 Rheumatoid Arthritis Vaccine in DepoVax(TM)
Oct 18, 2010 8:28am EDT Immunovaccine Signs Agreement With National Research Council to Evaluate Carbohydrate-Based Vaccine
Oct 13, 2010 7:48pm EDT Immunovaccine Inc. and Defence Research and Development Canada Advance Potential Melioidosis Vaccine Candidate
Sep 28, 2010 4:23am EDT Immunovaccine to Present Preclinical DepoVax(TM) Therapeutic Cancer Vaccine Research at the International Society for Biological Therapy of Cancer (iSBTc) Conference
Sep 09, 2010 1:00pm EDT Immunovaccine to Present at the Rodman & Renshaw 12th Annual Healthcare Conference